H

Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267

Watchlist Manager
Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267
Watchlist
Price: 4.32 CNY -1.82%
Market Cap: ¥8.9B

Profitability Summary

Hunan Er-Kang Pharmaceutical Co Ltd's profitability score is 29/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score
29/100
Profitability
Score

Margins

Earnings Waterfall
Hunan Er-Kang Pharmaceutical Co Ltd

Margins Comparison
Hunan Er-Kang Pharmaceutical Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267
9.1B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
97.1B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Hunan Er-Kang Pharmaceutical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267
9.1B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
97.1B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Hunan Er-Kang Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate